Kodiak Sciences Inc.
General ticker "KOD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $825.5M (TTM average)
Kodiak Sciences Inc. follows the US Stock Market performance with the rate: 47.8%.
Estimated limits based on current volatility of 3.9%: low 33.90$, high 36.69$
Factors to consider:
- Total employees count: 111 (-0.9%) as of 2023
- Top business risk factors: Product development risks, Market competition, Regulatory and compliance, Manufacturing disruptions, Economic downturns and volatility
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.84$, 33.12$]
- 2026-12-31 to 2027-12-31 estimated range: [5.86$, 19.28$]
Financial Metrics affecting the KOD estimates:
- Negative: with PPE of -6.5 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Investing cash flow per share per price, % of -0.03 > -0.60
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: 42.59 < Shareholder equity ratio, % of 44.77 <= 64.29
Short-term KOD quotes
Long-term KOD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $277.32MM | $186.85MM | $234.39MM |
| Operating Income | $-277.32MM | $-186.85MM | $-234.39MM |
| Non-Operating Income | $16.83MM | $10.64MM | $4.42MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $206.30MM | $126.09MM | $182.37MM |
| Income(Loss) | $-260.49MM | $-176.21MM | $-229.97MM |
| Net Income(Loss)* | $-260.49MM | $-176.21MM | $-229.97MM |
| Stockholders Equity | $265.78MM | $150.29MM | $157.38MM |
| Assets | $479.37MM | $335.58MM | $351.53MM |
| Operating Cash Flow | $-154.18MM | $-117.32MM | $-136.01MM |
| Capital expenditure | $41.43MM | $0.40MM | $0.51MM |
| Investing Cash Flow | $249.23MM | $-0.76MM | $-0.51MM |
| Financing Cash Flow | $0.03MM | $0.50MM | $178.30MM |
| Earnings Per Share** | $-4.97 | $-3.35 | $-4.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.